Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits

Kidney International

Volumn 75, Issue 4, 2009, Pages 420-427

  Czarnecki, Peter G ^a   Lager, Donna J ^a   Leung, Nelson ^a   Dispenzieri, Angela ^a   Cosio, Fernando G ^a   Fervenza, Fernando C ^a  

^a Mayo Clinic   (United States)

Author keywords

Fibrillary; Gammopathy; Glomerulonephritis; Kidney; Monoclonal; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; MELPHALAN; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

ADULT; AGED; ALLOGRAFT; ALLOTRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FIBRILLARY GLOMERULONEPHRITIS; FOLLOW UP; GLOMERULONEPHRITIS; GRAFT FAILURE; GRAFT SURVIVAL; HEMATOLOGIC MALIGNANCY; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MONOCLONAL IMMUNOGLOBULINEMIA AND FIBRILLARY DEPOSIT; OUTCOME ASSESSMENT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; THROMBOEMBOLISM;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARAPROTEINEMIAS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 59149084228     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.577     Document Type: Article

References (30)

1. Iskandar SS, Falk RJ, Jennette JC. Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int 1992; 42: 1401-1407.
2. Duffy JL, Khurana E, Susin M et al. Fibrillary renal deposits and nephritis. Am J Pathol 1983; 113: 279-290.
3. Hvala A, Ferluga D, Vizjak A et al. Fibrillary noncongophilic renal and extrarenal deposits: a report on 10 cases. Ultrastruct Pathol 2003; 27: 341-347.
4. Rosenstock JL, Markowitz GS, Valeri AM et al. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int 2003; 63: 1450-1461.
5. Fogo A, Qureshi N, Horn RG. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 1993; 22: 367-377.
6. Alpers CE, Rennke HG, Hopper Jr J et al. Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features. Kidney Int 1987; 31: 781-789.
7. Pronovost PH, Brady HR, Gunning ME et al. Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/ immunotactoid glomerulopathy. Nephrol Dial Transplant 1996; 11: 837-842.
8. Brady HR. Fibrillary glomerulopathy. Kidney Int 1998; 53: 1421-1429.
9. Alpers CE. Fibrillary glomerulonephritis and immunotactoid glomerulopathy: two entities, not one. Am J Kidney Dis 1993; 22: 448-451.
10. Alpers CE. Glomerulopathies of dysproteinemias, abnormal immunoglobulin deposition, and lymphoproliferative disorders. Curr Opin Nephrol Hypertens 1994; 3: 349-355.
11. Alpers CE. Immunotactoid (microtubular) glomerulopathy: an entity distinct from fibrillary glomerulonephritis? Am J Kidney Dis 1992; 19: 185-191.
12. Korbet SM, Schwartz MM, Lewis EJ. The fibrillary glomerulopathies. Am J Kidney Dis 1994; 23: 751-765.
13. Ferrario F, Schiaffino E, Boeri R. Fibrillary and immunotactoid glomerulopathies. Ren Fail 1998; 20: 801-808.
14. Cadnapaphornchai P, Sillix D. Recurrence of monoclonal gammopathy-related glomerulonephritis in renal allograft. Clin Nephrol 1989; 31: 156-159.
15. Sturgill BC, Bolton WK. Non-amyloidotic fibrillary glomerulopathy (abstract). Kidney Int 1989; 35: 233.
16. Korbet SM, Rosenberg BF, Schwartz MM et al. Course of renal transplantation in immunotactoid glomerulopathy. Am J Med 1990; 89: 91-95.
17. Samaniego M, Nadasdy GM, Laszik Z et al. Outcome of renal transplantation in fibrillary glomerulonephritis. Clin Nephrol 2001; 55: 159-166.
18. Kebler R, Kithier K, McDonald FD et al. Rapidly progressive glomerulonephritis and monoclonal gammopathy. Am J Med 1985; 78: 133-138.
19. Esparza AR, Chazan JA, Nayak RN et al. Fibrillary (immunotactoid) glomerulopathy. A possible role for kappa light chain in its etiology and/ or pathogenesis. Am J Surg Pathol 1991; 15: 632-643.
20. Orfila C, Meeus F, Bernadet P et al. Immunotactoid glomerulopathy and cutaneous vasculitis. Am J Nephrol 1991; 11: 67-72.
21. Rollino C, Coppo R, Mazzucco G et al. Monoclonal gammopathy and glomerulonephritis with organized microtubular deposits. Am J Kidney Dis 1990; 15: 276-280.
22. Saxena R, Frankel WL, Sedmak DD et al. Recurrent type I membranoproliferative glomerulonephritis in a renal allograft: successful treatment with plasmapheresis. Am J Kidney Dis 2000; 35: 749-752.
23. Rosenmann E, Eliakim M. Nephrotic syndrome associated with amyloid-like glomerular deposits. Nephron 1977; 18: 301-308.
24. Dabade TS, Grande JP, Norby SM et al. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study. Am J Transplant 2008; 8: 1318-1322.
25. Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance. Br J Haematol 2006; 134: 573-589.
26. Kyle RA, Therneau TM, Rajkumar SV et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006; 354: 1362-1369.
27. Kyle RA, Therneau TM, Rajkumar SV et al. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc 2004; 79: 859-866.
28. Korbet SM, Schwartz MM, Rosenberg BF et al. Immunotactoid glomerulopathy. Medicine (Baltimore) 1985; 64: 228-243.
29. Leung N, Lager DJ, Gertz MA et al. Long-term outcome of renal transplantation in light-chain deposition disease. Am J Kid Dis 2004; 43: 147-153.
30. Short AK, O'Donoghue DJ, Riad HN et al. Recurrence of light chain nephropathy in a renal allograft. A case report and review of the literature. Am J Nephrol 2001; 21: 237-240.